Sabre leads $8m round for Indian dermatology specialist
Sabre Partners as led an $8 million Series B round of funding for Vyome Biosciences, an Indian bio-pharmaceutical company that specializes in dermatology.
Existing investors Kalaari Capital and Aarin Capital also participated. According to AVCJ Research, Vyome raised $1 million in seed funding from Navam Capital in November 2010 and then a $3.3 million Series A round from Navam, Kalaari and Aarin in September 2012.
The company was founded in 2010 by Shiladitya Sengupta, co-chair at the Center for Regenerative Therapeutics at Brigham & Women's Hospital in Boston and an assistant professor at Harvard Medical School, Rajesh Gokhale, director of the Institute of Genomics & Integrative Biology in Delhi, and Rajiv Mantri, founder and executive director at Navam. The current CEO is N. Venkat, a consumer products and life sciences industry veteran.
Vyome develops treatments by modifying active agents in molecules based on the genomic information of disease-causing microorganisms. It has three platforms catering to consumer products and pharmaceutical applications across dermatology, skin care and hair care.
The company is developing molecules that can be used to kill dandruff-causing fungus and antibiotics that shut down acne-causing bacteria. Clinical research has been completed on both products and they are in the initial stages of the US Food and Drug Administration approval process. The new capital will be used to support the commercialization of these and other treatments.
"The company is applying science and critical understanding to develop unique platform technologies and products for the $20 billion global dermatology market," Rajiv Maliwal, founder and managing partner at Sabre, said in a statement.
Sabre has invested more than $325 million in financial services, infrastructure and healthcare in India over the past decade, distributing over $1.6 billion in proceeds. One of its most successful investments was the restructuring of Centurion Bank, which was sold to HDFC Bank in 2008.
More on Venture
Latest News
Asian GPs slow implementation of ESG policies - survey
Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...
Singapore fintech start-up LXA gets $10m seed round
New Enterprise Associates (NEA) has led a USD 10m seed round for Singapore’s LXA, a financial technology start-up launched by a former Asia senior executive at The Blackstone Group.
India's InCred announces $60m round, claims unicorn status
Indian non-bank lender InCred Financial Services said it has received INR 5bn (USD 60m) at a valuation of at least USD 1bn from unnamed investors including “a global private equity fund.”
Insight leads $50m round for Australia's Roller
Insight Partners has led a USD 50m round for Australia’s Roller, a venue management software provider specializing in family fun parks.